Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits 2016-08-11
  2. An overview of APP processing enzymes and products 2010-03-01

Studies

2 studies carry this tag.

Date range

2010 to 2016

Top journals

  • Human molecular genetics 1
  • Neuromolecular medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Human molecular genetics 2016-08-11 TREM2 and immune genetics

    Recent studies have indicated that innate immune signalling molecules are involved in late-onset Alzheimer's disease (LOAD) risk.

  2. An overview of APP processing enzymes and products

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuromolecular medicine 2010-03-01 Risk genes beyond APOE

    The generation of amyloid beta-peptide (A beta) by enzymatic cleavages of the beta-amyloid precursor protein (APP) has been at the center of Alzheimer's disease (AD) research.

All topic tags with their study counts